OncLive: Dr. Mesa on rechallenging with JAK inhibitor therapy in MPNs

July 23, 2020

In this video, Ruben A. Mesa, MD, director of the Mays Cancer Center at UT Health San Antonio MD Anderson Cancer Center, discusses the potential clinical benefit of rechallenging with JAK inhibitor therapy in patients with myeloproliferative neoplasms (MPNs). Watch the interview.




Primera Hora: Leaders summoned to fight against COVID

July 22, 2020

Nationally renowned transplant surgeon Dr. Francisco Cigarroa, from UT Health in San Antonio, asks that the Hispanic community fight united against the coronavirus. He urges people to wear a mask, wash their hands, stay at home and social distance. Read the story.